Mr. Jagdip Bal reports

UMBRAL ACQUIRES ADDITIONAL 25% INTEREST IN PHYEINMED, A HEALTH CANADA ACMPR STAGE 5 REVIEW STAGE APPLICANT

Umbral Energy Corp. has signed a binding letter of intent (LOI) to acquire an additional 25-per-cent interest in PhyeinMed Inc., a Health Canada stage 5 review-stage applicant under the access to cannabis for medical purposes regulations (ACMPR). With this purchase, Umbral now holds 75-per-cent ownership of PhyeinMed.

Jagdip Bal, president and chief executive officer, states: "Umbral has quickly positioned itself as the majority owner of an exceptional company in PhyeinMed. We are eager to assist PhyeinMed in their mission of becoming a licensed producer in Canada."

Currently, PhyeinMed is owned 50 per cent by Estek Ventures Corp. This agreement will see Umbral acquire an additional 25 per cent through its wholly owned subsidiary, 1005477 B.C. Inc. The revised ownership of PhyeinMed will be Umbral with 75 per cent and Estek with 25 per cent.

The terms of the agreement are as follows:

1. $100,000 cash payment:
   1. $50,000 due on signing of the LOI (paid);
   2. $50,000 due on completion of the share purchase agreement;
2. Seven million shares in Umbral Energy;
3. Released over a three-year escrow period:
   1. 100 per cent of all shares released from escrow upon ACMPR stage 7 licence approval, awarded if this is accomplished prior to the 36 months;
   2. 100 per cent of all shares released from escrow as of 36 months, if not released prior;
4. Estek to be granted a bonus of one million shares of Umbral Energy upon final award of ACMPR stage 7 licence approval; no escrow on this award.

Prebuild preparations have started, and PhyeinMed has started the preliminary work required to complete the renovations and security requirements for the 13-acre property with a 10,000-square-foot steel-framed building in Falkland, B.C. Once an affirmation letter has been received from Health Canada, PhyeinMed will be prepared for an inspection.

PhyeinMed's chief executive officer, Debra Senger, and owner of Estek Ventures, states: "I am very pleased with the recent developments; I believe we as a team, Umbral and myself, having an interest in the public company will be far more committed to the direction of the company as one cohesive unit. I look forward to our journey, and I am excited for the future"

The company also plans to build through potential partnerships, international opportunities, strategic alliances, accessory and ancillary relationships with an emphasis on future revenue generating cannabis opportunities.

About Umbral Energy Corp.

The company is currently listed as a junior resource issuer having mineral exploration projects.

The company has mineral exploration projects in Utah, Nevada and Quebec. In addition, the company has an interest in PhyeinMed, which has applied for a licence from Health Canada to legally grow and sell medical marijuana.

We seek Safe Harbor.